Rain Therapeutics Inc.

NASDAQ:RAIN

2.62 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -4.534-0.437-75.724-51.394-21.083-10.902
Depreciation & Amortization 0.0120.0130.080.0710.0520.028
Deferred Income Tax 0000.0800
Stock Based Compensation 2.8350.0044.8553.0920.8650.236
Change In Working Capital 00.1718.935.1881.609-0.827
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.0280.2851.0345.2880.555-0.249
Other Working Capital 0-0.1147.896-0.11.054-0.578
Other Non Cash Items 0.3650.011-1.345.57.3260.283
Operating Cash Flow -1.323-0.238-63.199-37.463-11.231-11.182
Investing Activities:
Investments In Property Plant And Equipment 0-0.264-0.008-2.628-5.191-0.144
Acquisitions Net 0002.500
Purchases Of Investments 00-76.198-163.55700
Sales Maturities Of Investments 00123.447.9500
Other Investing Activites -0.04600-2.500
Investing Cash Flow -0.046-0.26447.194-118.235-5.191-0.144
Financing Activities:
Debt Repayment 00.4470000
Common Stock Issued 0.740.0020133.3660.0010
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 1.364-0.00953.18121.61569.4912.5
Financing Cash Flow 1.3640.4453.18121.61569.4912.5
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -0.005-0.06337.175-34.08353.069-8.826
Cash At End Of Period 0.0330.03761.95524.7858.8635.794